SG Americas Securities’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Sell |
12,369
-17,268
| -58% | -$194K | ﹤0.01% | 2208 |
|
|
2025
Q1 | $169K | Buy |
29,637
+9,342
| +46% | +$53.3K | ﹤0.01% | 2367 |
|
|
2024
Q4 | $199K | Buy |
+20,295
| New | +$199K | ﹤0.01% | 1902 |
|
|
2024
Q3 | – | Sell |
-554
| Closed | -$7K | – | 3004 |
|
|
2024
Q2 | $7K | Sell |
554
-7
| -1% | -$88 | ﹤0.01% | 2379 |
|
|
2024
Q1 | $26K | Sell |
561
-535
| -49% | -$24.8K | ﹤0.01% | 2492 |
|
|
2023
Q4 | $74K | Buy |
1,096
+459
| +72% | +$31K | ﹤0.01% | 2590 |
|
|
2023
Q3 | $46K | Sell |
637
-226
| -26% | -$16.3K | ﹤0.01% | 2654 |
|
|
2023
Q2 | $64K | Sell |
863
-669
| -44% | -$49.6K | ﹤0.01% | 1844 |
|
|
2023
Q1 | $82K | Buy |
1,532
+505
| +49% | +$27K | ﹤0.01% | 2709 |
|
|
2022
Q4 | $69K | Buy |
1,027
+745
| +264% | +$50.1K | ﹤0.01% | 2532 |
|
|
2022
Q3 | $35K | Sell |
282
-149
| -35% | -$18.5K | ﹤0.01% | 2715 |
|
|
2022
Q2 | $41K | Sell |
431
-4,026
| -90% | -$383K | ﹤0.01% | 2977 |
|
|
2022
Q1 | $718K | Buy |
+4,457
| New | +$718K | 0.01% | 1463 |
|
|
2021
Q4 | – | Sell |
-3,252
| Closed | -$1.51M | – | 3051 |
|
|
2021
Q3 | $1.51M | Buy |
+3,252
| New | +$1.51M | 0.01% | 1394 |
|